Search

Author/Creator Du, Ruofei

7. INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial. (11th August 2017)

Authors:
Patt, Yehuda Z.; Murad, Waheed; Fekrazad, Mohammed H.; Baron, Ari D.; Bansal, Pranshu; Boumber, Yanis; Steinberg, Kim; Lee, Sang‐Joon; Bedrick, Ed; Du, Ruofei; Lee, Fa Chyi
Journal:
Cancer medicine
Issue:
Volume 6:Number 9(2017:Sep.)
Page Start:
2042
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Maternal comorbidity index and severe maternal morbidity among medicaid covered pregnant women in a US Southern rural state. (31st December 2023)

Authors:
Du, Ruofei; Ali, Mir M.; Sung, Yi-Shan; Pandit, Ambrish A.; Payakachat, Nalin; Ounpraseuth, Songthip T.; Magann, Everett F.; Eswaran, Hari
Journal:
Journal of maternal-fetal & neonatal medicine
Issue:
Volume 36:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. (27th April 2022)

Authors:
Figueiredo, Jane C; Hirsch, Fred R; Kushi, Lawrence H; Nembhard, Wendy N; Crawford, James M; Mantis, Nicholas; Finster, Laurel; Merin, Noah M; Merchant, Akil; Reckamp, Karen L; Melmed, Gil Y; Braun, Jonathan; McGovern, Dermot; Parekh, Samir; Corley, Douglas A; Zohoori, Namvar; Amick, Benjamin C; ...
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗